SCHEMBL6565982

SCHEMBL6565982

CCC(=O)c1cc(NC(=O)Nc2ccc(OC)cc2)ccc1OCc1ccc(-c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.50
POLB P06746 3/20 0.50
RAB9A P51151 3/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
C5AR1 P21730 1/20 0.49
HIF1A Q16665 1/20 0.49
ABCG2 Q9UNQ0 1/20 0.48
KDM4E B2RXH2 3/20 0.47
SAE1 Q9UBE0 1/20 0.47
UBA2 Q9UBT2 1/20 0.47
LRRK2 Q5S007 2/20 0.47
MEN1 O00255 6/20 0.47
SMPD1 P17405 1/20 0.47
PABPC1 P11940 1/20 0.47
NOX1 Q9Y5S8 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565921 0.92 LRRK2 (0.57) KMT2APOLBRAB9AC5AR1HIF1A
SCHEMBL6567986 0.91 SMPD1 (0.53) KMT2APOLBRAB9AKDM4EMEN1
SCHEMBL6566856 0.90 MEN1 (0.56) KMT2APOLBRAB9AHIF1AABCG2
SCHEMBL6568306 0.89 SMN1; SMN2 (0.53) KMT2APOLBRAB9AABCG2KDM4E
SCHEMBL6564446 0.86 MAPT (0.52) KMT2APOLBRAB9AABCG2KDM4E
SCHEMBL6564438 0.86 MEN1 (0.58) KMT2APOLBRAB9AABCG2KDM4E
SCHEMBL6568181 0.83 MAPT (0.68) KMT2APOLBRAB9ALRRK2MEN1
SCHEMBL6565019 0.82 MAPT (0.57) KMT2ARAB9AKDM4ELRRK2MEN1
SCHEMBL6567936 0.80 MAPT (0.54) KMT2APOLBRAB9AKDM4EMEN1
SCHEMBL6567947 0.80 MAPT (0.54) KMT2APOLBRAB9AKDM4ELRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 KMT2A 3137/4885POLB 3499/4885RAB9A 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.